Associated tags: Pharmacy, Health, AmerisourceBergen, Pharmaceutical, General Health, Patient, Pharmaceutical industry, Professional Services
Locations: FLORIDA, CALIFORNIA, OHIO, TEXAS, BELGIUM, MASSACHUSETTS, UNITED STATES, NORTH AMERICA, PENNSYLVANIA, MAINE, NEVADA, USA, CANADA, BRAZIL, NEW YORK
Veterinary,
Pharmaceutical,
Finance,
General Health,
Health,
Banking,
Professional Services,
Health Insurance,
Berkshire Hathaway,
Yale University,
Human resources,
University,
AmerisourceBergen,
JPMorgan Chase,
Bayer,
Economics,
RWTH Aachen University,
University of Cologne,
Retirement,
Acquisition,
Alleghany Corporation,
ABC,
Harvard Business School,
Development,
NYSE,
Management AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023.
Key Points:
- AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023.
- With the election of Mr. Baumann and Ms. Tyler, the Board of Directors will increase from ten to twelve members, ten of whom are independent.
- “We look forward to welcoming Mr. Baumann and Ms. Tyler to AmerisourceBergen’s Board of Directors.
- Ms. Tyler was a director at Alleghany Corporation from January 2019 until its acquisition by Berkshire Hathaway in October 2022.
Medical Supplies,
Communications,
Health,
General Health,
Publishing,
Pharmaceutical,
Avalon,
Partnership,
Pharmacy,
Good Neighbor Pharmacy,
Snack,
Exhibition,
Long-term care,
AmerisourceBergen,
COVID-19,
Woman,
Public policy,
Multimedia,
E-commerce,
Doctor of Philosophy,
Pharmacist,
MGM Grand Las Vegas,
Student,
Beauty,
Community,
Patient,
Point-of-care testing,
MGM Grand,
ThoughtSpot,
Order (mathematics),
African Americans,
Female,
Grocery store,
Hospital,
Online shopping Good Neighbor Pharmacy, a national independent pharmacy network offered through AmerisourceBergen, convened nearly 5,000 independent pharmacy owners and other partners to celebrate its annual, marquee event, the ThoughtSpot tradeshow and conference.
Key Points:
- Good Neighbor Pharmacy, a national independent pharmacy network offered through AmerisourceBergen, convened nearly 5,000 independent pharmacy owners and other partners to celebrate its annual, marquee event, the ThoughtSpot tradeshow and conference.
- This year’s event showcased the extraordinary collaboration, commitment and perseverance of the Good Neighbor Pharmacy network of pharmacists dedicated to improving community health.
- “We’re delighted to welcome our Good Neighbor Pharmacy members to another impactful and informative ThoughtSpot event that features innovations, resources and educational opportunities to advance our practice,” said Jennifer Zilka, President of Good Neighbor Pharmacy.
- Additionally, Good Neighbor Pharmacy – in partnership with the AmerisourceBergen Foundation – honored the winners of the inaugural Good Neighbor Pharmacy Scholarship program, supporting Black and African American graduate students pursuing a pharmacy career.
General Health,
Finance,
Banking,
Health,
Professional Services,
Share repurchase,
Telephone,
EDGAR,
Sale,
Goldman Sachs,
Prospectus,
S-3,
Form,
NYSE,
Security (finance) The Company is not issuing or selling any shares of its common stock in the offering, is not a party to the variable forward transactions and will not receive any proceeds from sales of the underwritten shares.
Key Points:
- The Company is not issuing or selling any shares of its common stock in the offering, is not a party to the variable forward transactions and will not receive any proceeds from sales of the underwritten shares.
- The concurrent share repurchase will be made under the Company’s share repurchase program and the repurchased shares will be held in treasury.
- The closing of the concurrent share repurchase will be conditioned upon the closing of the offering and therefore there can be no assurance that the concurrent share repurchase will be completed.
- The offering is not conditioned upon the completion of the concurrent share repurchase.
Retrieved on:
Wednesday, August 2, 2023
Oncology,
Professional Services,
Health,
Finance,
General Health,
Pharmaceutical,
Banking,
Civic,
American Association of People with Disabilities,
Table,
Diabetes,
AmerisourceBergen,
Telephone,
COVID-19,
Weight loss,
GAAP,
Interest expense,
Pharmacy,
Earnings per share,
Carbon,
TPG,
Delaware Valley,
Good Neighbor Pharmacy,
Acquisition,
Disability,
Webcast,
Growth,
Conference,
Bank,
Health insurance,
Video game,
Pharmaceutical industry,
Renewable energy,
Security (finance),
Risk management,
Cryptocurrency,
Music Operating income as a percentage of revenue was 1.00 percent in the third quarter of fiscal 2023, an increase of 19 basis points when compared to the prior year quarter.
Key Points:
- Operating income as a percentage of revenue was 1.00 percent in the third quarter of fiscal 2023, an increase of 19 basis points when compared to the prior year quarter.
- Diluted Earnings Per Share: Diluted earnings per share was $2.35 in the third quarter of fiscal 2023, a 22.4 percent increase compared to $1.92 in the previous fiscal year’s third quarter.
- Diluted Shares Outstanding: Diluted weighted average shares outstanding for the third quarter of fiscal 2023 were 204.4 million, a decrease of 7.4 million shares, or 3.5 percent, versus the prior fiscal year third quarter primarily as a result of share repurchases.
- Adjusted Diluted Earnings Per Share: Adjusted diluted earnings per share was $2.92 in the third quarter of fiscal 2023, an 11.5 percent increase compared to $2.62 in the previous fiscal year’s third quarter.
Research,
Managed Care,
General Health,
Pharmaceutical,
Telemedicine,
Virtual Medicine,
Data Management,
Apps,
Applications,
Technology,
Infectious Diseases,
Health Technology,
Science,
Health,
J.D. Power,
Pharmacy,
Good Neighbor Pharmacy,
AmerisourceBergen,
Long-term care,
Index,
Community,
Patient,
Customer satisfaction,
GNP,
Grocery store Good Neighbor Pharmacy (GNP), a national independent pharmacy network offered through AmerisourceBergen, today announced that it has been ranked “First in Customer Satisfaction with Chain Drug Store Pharmacies” in the J.D.
Key Points:
- Good Neighbor Pharmacy (GNP), a national independent pharmacy network offered through AmerisourceBergen, today announced that it has been ranked “First in Customer Satisfaction with Chain Drug Store Pharmacies” in the J.D.
- This is the 12th time that Good Neighbor Pharmacy has earned this recognition in the last 14 years and the network’s seventh consecutive win.
- “I’d like to extend my sincere congratulations to our Good Neighbor Pharmacy members on receiving this prestigious recognition from J.D.
- In addition to receiving the highest overall satisfaction ranking, Good Neighbor Pharmacy ranked #1 across six of the seven study factors, specifically:
“I am honored to see Good Neighbor Pharmacy emerge once again as Best Chain Drug Store Pharmacy for Customer Satisfaction in the J.D.
Professional Services,
Health,
Finance,
General Health,
Banking,
Pharmaceutical,
Telephone,
Webcast,
AmerisourceBergen,
NYSE,
ABC,
Fiscal,
Broadcasting AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange.
Key Points:
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange.
- Participating in the conference call will be:
The live call will be webcast via the Company’s website at investor.amerisourcebergen.com .
- Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
- Please check the website investor.amerisourcebergen.com for updates regarding the timing of the live webcasts and for replay information.
Retail,
Transport,
Pharmaceutical,
Insurance,
Software,
Medical Devices,
Supply Chain Management,
Hospitals,
Professional Services,
Logistics,
Technology,
Practice Management,
Managed Care,
Medical Supplies,
Data Analytics,
Health,
Specialty,
Health Insurance,
Partnership,
AmerisourceBergen,
Health care,
Intelligence,
Patient,
Risk,
Weather,
Triose ParcelShield Holdings, LLC ("ParcelShield"), the leading provider of technology-enabled predictive parcel tracking and patient engagement solutions for the healthcare industry, announces that Triose, Inc., part of AmerisourceBergen and the leading provider of intelligent healthcare supply chain solutions, has partnered with ParcelShield, using the company’s technology to help ensure its hospital, health system and healthcare network customers receive life-critical, time-sensitive medical shipments on time.
Key Points:
- ParcelShield Holdings, LLC ("ParcelShield"), the leading provider of technology-enabled predictive parcel tracking and patient engagement solutions for the healthcare industry, announces that Triose, Inc., part of AmerisourceBergen and the leading provider of intelligent healthcare supply chain solutions, has partnered with ParcelShield, using the company’s technology to help ensure its hospital, health system and healthcare network customers receive life-critical, time-sensitive medical shipments on time.
- With the use of ParcelShield’s solution, Triose will gain a more nuanced view of the delivery of critical medications to its healthcare provider customers and their patients.
- ParcelShield’s predictive analytics, tracking and monitoring capabilities will enable Triose to track and monitor the entire patient medication delivery journey, as well as predict, identify, and manage packages at risk of shipping delays.
- The solution will also allow Triose to enhance its communications with customers by giving proactive, real-time package tracking and delivery updates.
Finance,
Professional Services,
Biotechnology,
Other Health,
Managed Care,
Health,
Pharmaceutical,
Asset Management,
Oncology,
AmerisourceBergen,
Partnership,
Acquisition,
Physician,
NYSE,
ABC,
Cryptocurrency,
Nursing,
TPG TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.
Key Points:
- TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.
- TPG has acquired a majority interest in OneOncology, and AmerisourceBergen has acquired a minority interest in the company.
- OneOncology’s affiliated practices, physicians, and management team have also retained a minority interest in the company.
- The partnership provides OneOncology with additional resources to grow its platform and invest behind clinical, operational, and technical capabilities to continue to deliver high-quality, comprehensive patient care.
General Health,
Finance,
Health,
Professional Services,
Pharmaceutical,
AmerisourceBergen,
Treasury,
Walgreens Boots Alliance,
Share repurchase,
NYSE,
ABC,
Security (finance),
Car rental,
Cryptocurrency AmerisourceBergen Corporation (NYSE: ABC) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended.
Key Points:
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended.
- AmerisourceBergen intends to repurchase shares from Walgreens Boots Alliance at the per share price equal to the price in the Rule 144 transaction.
- The concurrent share repurchase will be made under AmerisourceBergen’s share repurchase program and the repurchased shares will be held in treasury.
Business development,
Partnership,
Housing,
Health,
AmerisourceBergen,
Health equity,
Cancer,
Patient,
Hospital,
Mylab Discovery Solutions,
Entrepreneurship,
Transport,
Food security,
Nursing BOSTON, May 11, 2023 /PRNewswire/ -- Patient Discovery Solutions, a leader in health equity solutions that harness the power of patient-centered technology and real-world data to help achieve better health outcomes, joins global healthcare company AmerisourceBergen's Trusted Vendor Program. The collaboration enables community oncology practices, hospitals, and health systems nationwide access to Patient Discovery's Equitable Care Platform, allowing care providers to proactively identify and address social determinants of health to better inform providers and help improve outcomes for cancer patients.
Key Points:
- As a partner, Patient Discovery's Equitable Care Platform will seamlessly integrate within a participating practice's current systems, helping to improve information exchange for delivering equitable care across multiple sites of care.
- Patient Discovery's mission to merge the patient's life outside the clinical setting with their clinical care path aligns perfectly with AmerisourceBergen's corporate priority to advance health equity.
- We look forward to bringing our team's passion and the power of our network to utilize the Patient Discovery equitable care platform to advance health equity in a more meaningful way," said Charley Deckers, VP, Business Development and Alliances, Specialty Physician Services at AmerisourceBergen.
- Moving forward, this new platform will enable care teams to deliver targeted care plans aimed at the whole person, improving the patient experience, and reducing the total cost of care.
